re.Mind Capital logo

re.Mind Capital

Europe, NA - Malta, Malta, Sliema

Description

re.Mind Capital is a venture capital fund founded by Christian Angermayer, together with partners Jan Hardorp and Max de Vere.

Investor Profile

re.Mind Capital has made 17 investments, with 0 in the past 12 months and 24% as lead.

Stage Focus

  • Series A (47%)
  • Series B (18%)
  • Seed (18%)
  • Series Unknown (6%)
  • Private Equity (6%)
  • Pre Seed (6%)

Country Focus

  • United States (71%)
  • United Kingdom (18%)
  • Switzerland (6%)
  • Germany (6%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Neuroscience
  • Mental Health
  • Software
  • Wellness
  • Artificial Intelligence (Ai)
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does re.Mind Capital frequently co-invest with?

Forepont Capital Partners
North America, New York, United States, New York
Co-Investments: 2
Mubadala Capital Ventures
North America, California, United States, San Francisco
Co-Investments: 2
WPSS Investments
North America, New York, United States, New York
Co-Investments: 2
What If Ventures
North America, Texas, United States, Frisco
Co-Investments: 3
PsyMed Ventures
North America, California, United States, San Francisco
Co-Investments: 3
PS
North America, Illinois, United States, Highland Park
Co-Investments: 3
Presight Capital
North America, California, United States, West Hollywood
Co-Investments: 3
Iter Investments
North America, Florida, United States, Fort Lauderdale
Co-Investments: 2
Apeiron Investment Group
Europe, NA - Malta, Malta, Sliema
Co-Investments: 2
W
North America, New York, United States, New York
Co-Investments: 3

Which angels does re.Mind Capital often collaborate with?

TR
North America, Rhode Island, United States, Providence
Shared Deals: 1
MM
North America, Texas, United States, Houston
Shared Deals: 1
SB
North America, California, United States
Shared Deals: 1
JD
North America, California, United States, Palo Alto
Shared Deals: 1
PT
North America, California, United States, San Francisco
Shared Deals: 1
NB
North America, California, United States, Los Angeles
Shared Deals: 1
MH
North America, California, United States, San Francisco
Shared Deals: 1
CS
North America, Washington, United States, Kirkland
Shared Deals: 1
AB
North America, New York, United States, New York
Shared Deals: 1
RG
North America, Nevada, United States, Crystal Bay
Shared Deals: 1

What are some of recent deals done by re.Mind Capital?

Motif Neurotech

Houston, Texas, United States

Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses.

Health CareMedical
Series AJan 24, 2024
Amount Raised: $18,750,000
Precision Neuroscience

New York, New York, United States

Precision Neuroscience is a neural platform that engages in brain-computer interface technology.

MedicalMedical DeviceNeuroscienceProduct Research
Series BJan 25, 2023
Amount Raised: $41,000,000
Sensorium Therapeutics

Boston, Massachusetts, United States

Sensorium Therapeutics is a drug discovery platform that develops novel FDA-approved psychoactive medicines.

Health CareMedicalTherapeutics
Series AOct 4, 2022
Amount Raised: $30,000,000
iLoF

London, England, United Kingdom

iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized medicine.

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMachine LearningMedical DevicePrecision Medicine
SeedJul 28, 2022
Amount Raised: $4,100,000
Alena

London, England, United Kingdom

Alena uses computational neuroscience to deliver tailored mental health solutions.

Health CareMental HealthmHealthMobileSoftwareWellness
SeedMar 23, 2022
Amount Raised: $2,700,000
Rejuveron Life Sciences

Schlieren, Zurich, Switzerland

Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.

BiotechnologyHealth CareMedical
Series BMar 17, 2022
OccamzRazor

New York, New York, United States

OccamzRazor is a combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development.

Artificial Intelligence (AI)BiotechnologyMachine LearningNeuroscience
Series AMar 8, 2022
Amount Raised: $6,100,000
CereGate

Munich, Bayern, Germany

CereGate a San Diego,CA-based developer of a a new software platform

Medical DeviceSoftware
Series AJan 12, 2022
OpenBCI

Brooklyn, New York, United States

OpenBCI creates wearable neurotechnology software and hardware

ElectronicsHardwareHuman Computer InteractionNeuroscienceOpen SourceQuantified SelfSoftwareWearables
Series UnknownDec 15, 2021
Kanna Health

Sevenoaks, Kent, United Kingdom

Developing novel therapeutics from the kanna plant

Biotechnology
Pre SeedOct 31, 2021
Amount Raised: $6,157,349